Pharma Stock Offers 6% Yield Amid Pipeline Expansion

• Pfizer offers a 6% dividend yield, an alternative to Treasury bonds.
• The pharmaceutical company is expanding its portfolio beyond its COVID-19 vaccine.
• Investors have the potential for significant upside while receiving dividends.
• The expansion aims to drive future growth and value for shareholders.
• Pfizer's strategy includes diversifying its product pipeline.